Answers are grounded in this paper and cite their sources.
A patient receiving adjuvant chemoimmunotherapy for breast carcinoma developed urticaria secondary to cyclophosphamide, one of the drugs of the chemotherapy regimen. Chlorambucil, another alkylating agent, was substituted with no cross-sensitivity noted.
No takes yet. Share an insight, caveat, or question.
Allan N. Krutchik (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: